Agios Pharmaceuticals, Inc. (AGIO)
28.17
-0.56
(-1.95%)
USD |
NASDAQ |
May 15, 16:00
28.16
-0.01
(-0.04%)
After-Hours: 20:00
Agios Pharmaceuticals Shareholders Equity (Quarterly) : 1.109B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Apellis Pharmaceuticals, Inc. | 414.92M |
| Amgen, Inc. | 9.19B |
| MannKind Corp. | -59.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.185B |
| Total Liabilities (Quarterly) | 75.88M |
| Debt to Equity Ratio | 0.0322 |
| Current Ratio | 14.19 |
| Net Debt Paydown Yield | 0.21% |